Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis
Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis.
ClinicalTrials.gov ID
NCT05838144
Lead Sponsor
South Valley UniversityOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Not Applicable
Enrollment
20Estimated
Last Update Posted
Jul 18, 2023Actual
Start Date
Aug 1, 2023Estimated
Primary Completion Date
Sep 30, 2023Estimated
Completion Date
Oct 20, 2023Estimated
Official Title
Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis.
Brief Summary
Acapella group. Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program .
Only routine physical therapy program group ( control group). Will only take medications and routine chest physical therapy program.
Detailed Description
Acapella group.Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program.
Only routine physical therapy program group( control group). Will only take medications and routine chest physical therapy program Spirometer measures such as forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1) will be measured for every patient before and after the end of 7 days.
Bronchiectasis
Acapella device
Only routine chest physical therapy program
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
bronchiectasis patients.
Age range between 40 to 55 years old of both gender.